The trademark application AMVERSIO was filed by Veriton Pharma Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 8, 2020, and it was registered by office on December 17, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 29, 2020. Change of name and professional address of the trademark registration was recorded on October 23, 2022. Appointment and Replacement of representative of the trademark registration was recorded on December 4, 2022.